This symposium will feature an international line up including speakers from AstraZeneca, Bicycle Therapeutics, GlaxoSmithKline, The Institute of Cancer Research, Spero Therapeutics and UCB, presenting on the discovery and development of novel therapeutic agents which have recently progressed towards or into clinical trials. The programme includes a variety of mechanistic approaches and will cover therapeutic areas including oncology, anti-infectives and inflammation.

Dr Mark Stewart (Team Leader, Medicinal Chemistry) will be attending.